Reproductive outcomes in women with hypogonadotrophic hypogonadism, a case series study

• Published in: Middle East Fertility Society Journal Vol. 26; no. 1; pp. 1 - 6
• Main Authors: Abdelaal, Ahmed Elsayed, Behery, Mohamed Atef, Abdelkawi, Ahmed Farouk
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 19.04.2021; Springer; Springer Nature B.V; SpringerOpen
• Subjects: Amenorrhea; Birth control; Birth rate; Body mass index; Embryos; Estrogens; Gonadotropin; Hypogonadism; Hypogonadotrophic; ICSI; In vitro fertilization; Infertility; Medicine; Medicine & Public Health; Miscarriage; Outcome; Ovaries; Ovulation; Pituitary hormones; Pregnancy; Pregnancy rate; Reproduction; Statistical analysis; Women; United States > US; Pregnancy rate; Reproduction; ICSI; Outcome; Hypogonadism; Hypogonadotrophic
• DOI: 10.1186/s43043-021-00055-6
• ISSN: 1110-5690

Background Hypogonadotropic hypogonadism (HH) is a rare condition in which there is gonadal hypofunction due to absence of gonadotropin drive. In this condition, there are very low serum levels of gonadotropins. Pituitary gland may itself have some disease or disorder, or there may be loss of gonadotropin-releasing hormone (GnRH) pulses from the hypothalamus. The pharmacological interventions in HH women formed the basis for superovulation strategies for assisted reproduction techniques (ART) with a special reference to the role of LH and its impact on oocyte and embryo quality. Results The medians ±inter quartile ranges for number of oocytes retrieved, number of MII oocytes, and number of embryos transferred were 5±7, 4±3, and 3±1 respectively. The pregnancy rate was 31.5% for this group of patients. The live birth rate and miscarriage rate were 21% and 11.5% respectively. Conclusion The reproductive outcomes of patients of hypogonadotrophic hypogonadism are reasonable after ICSI and clinical trials are recommended to corroborate this concern.